16 - 30 of 184 Items

Clinical vignette2022, feb 23
Review article2022, apr 5

Chronic myeloid leukemia: where do we stand, where can we go?

Krzysztof Lewandowski, Jakub Lewandowski

Vol 53, No 3 (2022)

Review article

Acta Haematol Pol 2022;53(3):153-165.
Original research article2022, jun 5

Treosulfan-based conditioning vs. low-dose busulfan-based conditioning for allogeneic hematopoietic stem cell transplantation: a cost-utility analysis in Poland

Paweł Kawalec, Przemysław Holko, George Bungey, Owen Moseley, Magdalena Żegleń, Mirosław Markiewicz

Vol 53, No 3 (2022)

Original research article

Acta Haematol Pol 2022;53(3):191-200.
Original research article2022, jun 6

Vaccinations following CAR-T cell therapy: summary of reported cases and state-of-the-art review of current recommendations

Jan Styczyński, Tomasz Styczyński, Jagoda Sadlok, Magdalena Woźniak, Dorota Rutkowska

Vol 53, No 3 (2022)

Original research article

Acta Haematol Pol 2022;53(3):207-214.
Review article2022, may 23

CAR-T therapy in mantle cell lymphoma: a review of the current literature

Joanna Romejko-Jarosińska

Vol 53, No 3 (2022)

Review article

Acta Haematol Pol 2022;53(3):166-175.
Review article2022, aug 1

Supportive care in multiple myeloma

Artur Jurczyszyn, Grzegorz Charliński, David H. Vesole

Vol 53, No 4 (2022)

Review article

Acta Haematol Pol 2022;53(4):227-240.
Original research article2022, jun 2

Usefulness of training based on outcome of transfusion committee report: assessment by personnel involved in blood therapy

Jolanta Antoniewicz-Papis, Agata Mikołowska, Krzysztof Sutkowski

Vol 53, No 3 (2022)

Original research article

Acta Haematol Pol 2022;53(3):183-190.
Original research article2022, jun 6

Survival in patients with multiple myeloma: a real-life single-center study

Marek Rodzaj, Anna Morawska-Krekora, Malgorzata Razny, Beata Jakubas

Vol 53, No 3 (2022)

Original research article

Acta Haematol Pol 2022;53(3):201-206.
Review article2022, may 25

Outpatient CAR-T therapy

Dominik Dytfeld, Lida Gil

Vol 53, No 3 (2022)

Review article

Acta Haematol Pol 2022;53(3):180-182.
Clinical vignette2022, jun 10

Primary refractory primary mediastinal lymphoma treated with CAR-T: new possibilities and challenges

Krzysztof Żyłka, Dominik Dytfeld, Lidia Gil

Vol 53, No 3 (2022)

Clinical vignette

Acta Haematol Pol 2022;53(3):215-217.
Clinical vignette2022, may 22

Role of Bradyrhizobium enterica in gastrointestinal graft-versus-host disease

Cem Selim, Murat Telli, Zahit Ali Bolaman, Irfan Yavaşoğlu

Vol 53, No 3 (2022)

Clinical vignette

Acta Haematol Pol 2022;53(3):221-223.
Clinical vignette2022, jun 10

Extramedullary plasmacytoma of the larynx manifesting as chronic hypertrophic laryngitis

Elżbieta Szczepanek, Anna Rzepakowska, Agnieszka Końska, Kazimierz Niemczyk, Iwona Hus, Jakub Grzybowski, Krzysztof Jamroziak

Vol 53, No 3 (2022)

Clinical vignette

Acta Haematol Pol 2022;53(3):218-220.
Clinical vignette2022, aug 4

Double transformation of relapsing juvenile myelomonocytic leukemia to refractory acute myeloid leukemia

Tomasz Styczyński, Jagoda Sadlok, Monika Richert-Przygońska, Robert Dębski, Małgorzata Kubicka, Beata Kuryło-Rafińska, Krzysztof Czyżewski

Vol 53, No 4 (2022)

Clinical vignette

Acta Haematol Pol 2022;53(4):295-297.
Original research article2022, aug 4

Neutropenic enterocolitis and multidrug-resistant bacteria colonization in lymphoma patients undergoing autologous stem cell transplantation

Monika Joks, Joanna Rupa-Matysek, Magdalena Matuszak, Anna Łojko-Dankowska, Lidia Gil

Vol 53, No 4 (2022)

Original research article

Acta Haematol Pol 2022;53(4):258-266.